Healthcare Nov 03, 2020 12:06 PM (GMT+8) · EqualOcean
Shanghai HaoYuan Chemexpress applied for a public listing on China’s Star Market and will attend the review meeting on November 9. It is a biotechnology company that focuses on developing small-molecular medicines and provides research and manufacturing services. The company plans to raise CNY 650 million to construct the research center in Shanghai and Anhui and produce active ingredients (AI) for 121.095 tons and liquidity.